Amylyx Pharmaceuticals Etf Price History

AMLX Etf  USD 1.88  0.07  3.59%   
If you're considering investing in Amylyx Etf, it is important to understand the factors that can impact its price. As of today, the current price of Amylyx Pharmaceuticals stands at 1.88, as last reported on the 25th of April, with the highest price reaching 1.99 and the lowest price hitting 1.87 during the day. Amylyx Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.15, which signifies that the etf had a -0.15% return per unit of risk over the last 3 months. Amylyx Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Amylyx Pharmaceuticals' Risk Adjusted Performance of (0.08), mean deviation of 4.87, and Standard Deviation of 11.29 to double-check the risk estimate we provide.
  
Amylyx Etf price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.1549

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsAMLX

Estimated Market Risk

 11.6
  actual daily
96
96% of assets are less volatile

Expected Return

 -1.8
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.15
  actual daily
0
Most of other assets perform better
Based on monthly moving average Amylyx Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Amylyx Pharmaceuticals by adding Amylyx Pharmaceuticals to a well-diversified portfolio.
Price Book
0.3143
Enterprise Value Ebitda
(5.79)
Price Sales
0.356
Shares Float
50.9 M
Wall Street Target Price
4.25

Amylyx Pharmaceuticals Etf Price History Chart

There are several ways to analyze Amylyx Pharmaceuticals Etf price data. The simplest method is using a basic Amylyx candlestick price chart, which shows Amylyx Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceFebruary 28, 202419.57
Lowest PriceApril 19, 20241.87

Amylyx Pharmaceuticals April 25, 2024 Etf Price Synopsis

Various analyses of Amylyx Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Amylyx Etf. It can be used to describe the percentage change in the price of Amylyx Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Amylyx Etf.
Amylyx Pharmaceuticals Price Daily Balance Of Power(0.58)
Amylyx Pharmaceuticals Price Rate Of Daily Change 0.96 
Amylyx Pharmaceuticals Price Action Indicator(0.09)
Amylyx Pharmaceuticals Accumulation Distribution 104,913 

Amylyx Pharmaceuticals April 25, 2024 Etf Price Analysis

When benchmark price declines in a down market, there may be an uptick in Amylyx Pharmaceuticals Etf price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Amylyx Pharmaceuticals intraday prices and daily technical indicators to check the level of noise trading in Amylyx Pharmaceuticals Etf and then apply it to test your longer-term investment strategies against Amylyx.

Amylyx Etf Price History Data

The price series of Amylyx Pharmaceuticals for the period between Fri, Jan 26, 2024 and Thu, Apr 25, 2024 has a statistical range of 17.7 with a coefficient of variation of 72.25. The prices are distributed with arithmetic mean of 9.78. The median price for the last 90 days is 14.61. The company issued dividends on March 28, 2018.
OpenHighLowCloseVolume
04/24/2024 1.97  1.99  1.87  1.88  1,739,802 
04/23/2024 1.97  2.02  1.94  1.95  1,471,434 
04/22/2024 1.90  2.03  1.90  1.98  1,555,613 
04/19/2024 1.98  2.02  1.85  1.87  2,503,479 
04/18/2024 2.01  2.03  1.96  1.98  1,034,036 
04/17/2024 2.04  2.08  1.99  2.00  1,734,078 
04/16/2024 2.07  2.07  1.98  2.01  2,156,188 
04/15/2024 2.10  2.14  1.99  2.07  3,707,227 
04/12/2024 2.28  2.29  2.07  2.10  2,824,749 
04/11/2024 2.45  2.56  2.25  2.29  3,735,005 
04/10/2024 2.60  2.65  2.45  2.46  3,168,446 
04/09/2024 2.67  2.82  2.62  2.67  1,957,529 
04/08/2024 2.65  2.87  2.61  2.69  2,224,539 
04/05/2024 2.61  2.67  2.53  2.62  1,577,589 
04/04/2024 2.69  2.86  2.54  2.61  2,828,477 
04/03/2024 2.58  2.73  2.55  2.63  1,699,858 
04/02/2024 2.70  2.71  2.52  2.62  2,898,284 
04/01/2024 2.84  2.89  2.71  2.71  2,625,298 
03/28/2024 2.86  2.98  2.83  2.84  1,875,892 
03/27/2024 2.76  2.95  2.72  2.88  3,250,578 
03/26/2024 2.76  2.79  2.68  2.74  1,690,714 
03/25/2024 2.74  2.82  2.67  2.71  2,196,706 
03/22/2024 2.89  2.92  2.72  2.74  1,916,448 
03/21/2024 3.03  3.03  2.85  2.87  1,918,260 
03/20/2024 2.91  3.03  2.82  2.97  1,860,951 
03/19/2024 2.81  3.00  2.80  2.93  2,380,841 
03/18/2024 3.13  3.15  2.76  2.86  5,937,285 
03/15/2024 3.12  3.27  3.06  3.24  3,941,044 
03/14/2024 3.39  3.39  3.13  3.17  4,002,951 
03/13/2024 3.44  3.50  3.33  3.44  4,897,162 
03/12/2024 3.67  3.85  3.35  3.44  8,330,451 
03/11/2024 3.33  3.83  3.25  3.80  17,505,626 
03/08/2024 2.99  4.39  2.70  3.36  61,466,830 
03/07/2024 18.92  19.18  18.66  18.97  1,509,675 
03/06/2024 18.87  19.32  18.66  19.05  1,633,912 
03/05/2024 19.11  19.42  18.40  18.85  1,220,578 
03/04/2024 19.20  19.22  17.94  19.14  1,839,998 
03/01/2024 19.04  19.20  18.58  18.71  1,125,744 
02/29/2024 19.80  19.95  18.63  18.85  1,861,356 
02/28/2024 18.77  19.59  18.77  19.57  1,539,125 
02/27/2024 17.90  19.02  17.86  19.00  1,795,426 
02/26/2024 17.73  18.61  17.53  17.56  1,492,765 
02/23/2024 18.73  19.24  17.36  17.65  2,224,340 
02/22/2024 16.55  19.75  16.49  18.54  5,680,540 
02/21/2024 14.96  15.36  14.89  15.31  1,406,208 
02/20/2024 15.81  16.00  14.81  14.91  1,140,319 
02/16/2024 15.42  16.03  15.20  15.88  1,299,482 
02/15/2024 15.21  15.52  14.98  15.38  816,668 
02/14/2024 15.19  15.24  15.00  15.07  823,243 
02/13/2024 15.80  16.12  14.95  14.96  935,745 
02/12/2024 16.21  16.40  16.00  16.25  763,026 
02/09/2024 15.57  16.42  15.43  16.14  1,331,634 
02/08/2024 15.16  15.67  15.14  15.46  549,815 
02/07/2024 15.51  15.52  15.11  15.12  592,411 
02/06/2024 15.38  15.72  15.18  15.56  660,828 
02/05/2024 15.93  15.99  15.24  15.30  665,471 
02/02/2024 16.35  16.60  15.73  15.78  943,520 
02/01/2024 16.03  16.67  15.75  16.57  1,105,804 
01/31/2024 15.76  16.22  15.73  16.00  1,052,476 
01/30/2024 15.92  15.92  15.28  15.62  891,969 
01/29/2024 15.38  16.15  14.98  15.79  1,119,741 

About Amylyx Pharmaceuticals Etf history

Amylyx Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Amylyx is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Amylyx Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Amylyx Pharmaceuticals stock prices may prove useful in developing a viable investing in Amylyx Pharmaceuticals
Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis and other neurodegenerative diseases. Amylyx Pharmaceuticals is listed under Biotechnology in the United States and is traded on NASDAQ Exchange exchange.

Amylyx Pharmaceuticals Quarterly Net Working Capital

382.62 Million

Amylyx Pharmaceuticals Etf Technical Analysis

Amylyx Pharmaceuticals technical etf analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, etf market cycles, or different charting patterns.
A focus of Amylyx Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Amylyx Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Aroon Oscillator Now

   

Aroon Oscillator

Analyze current equity momentum using Aroon Oscillator and other momentum ratios
All  Next Launch Module

Amylyx Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Amylyx Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Amylyx Etf historical price patterns, it is also worthwhile for investors to track various predictive indicators of Amylyx to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amylyx Pharmaceuticals. Also, note that the market value of any etf could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more information on how to buy Amylyx Etf please use our How to Invest in Amylyx Pharmaceuticals guide.
You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
The market value of Amylyx Pharmaceuticals is measured differently than its book value, which is the value of Amylyx that is recorded on the company's balance sheet. Investors also form their own opinion of Amylyx Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Amylyx Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amylyx Pharmaceuticals' market value can be influenced by many factors that don't directly affect Amylyx Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amylyx Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amylyx Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amylyx Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.